| Serial Number | 87835197 |
| Word Mark | FLEXREPORT |
| Filing Date | Thursday, March 15, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 6, 2022 |
| Registration Number | 6839622 |
| Registration Date | Tuesday, September 6, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 19, 2019 |
| Pseudo Mark | FLEX REPORT |
| Goods and Services | Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes for the detection of cancer; medical testing for diagnostic or treatment purposes for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; providing information to others in the fields of pathology, medical diagnostic testing and oncology testing, human disease and human medical conditions |
| Goods and Services | Genetic mapping for scientific purposes; gene sequencing for scientific purposes; molecular sequencing for scientific purposes; scientific study and analysis in the field of cancer; clinical research, namely, study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells, and cancer; providing medical research and scientific research information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing for scientific purposes, molecular sequencing for scientific purposes, cancer study and analysis, clinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; providing temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; providing on-line non-downloadable computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; genetic testing, rna testing and sequencing for scientific purposes; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; medical laboratory services, namely, clinical laboratory services and oncology reference laboratory services, providing medical research and scientific research information and reports, to others in the field of pathology, diagnostic testing, oncology testing; providing an interactive website featuring information and reports in the field of scientific research in pathology, diagnostic testing, oncology testing; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; medical laboratory services, namely, medical oncology reference laboratory services |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 22, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, April 15, 2012 |
| First Use In Commerce Date | Sunday, April 15, 2012 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 22, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | Sunday, April 15, 2012 |
| First Use In Commerce Date | Sunday, April 15, 2012 |
| Party Name | NeoGenomics Laboratories, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Fort Myers, FL 33912 |
| Party Name | NeoGenomics Laboratories, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Naples, FL 34103 |
| Party Name | NeoGenomics Laboratories, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Naples, FL 34103 |
| Event Date | Event Description |
| Wednesday, February 1, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 1, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 1, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 1, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 1, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, November 10, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, November 10, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, November 10, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, November 10, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, November 10, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, September 6, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 6, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Friday, August 5, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, August 4, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, July 13, 2022 | ASSIGNED TO EXAMINER |
| Monday, June 13, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 13, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 13, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, April 15, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, April 13, 2022 | USE AMENDMENT FILED |
| Wednesday, April 13, 2022 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, October 13, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 12, 2021 | SOU EXTENSION 5 GRANTED |
| Wednesday, October 6, 2021 | SOU EXTENSION 5 FILED |
| Wednesday, October 6, 2021 | TEAS EXTENSION RECEIVED |
| Friday, April 16, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, April 15, 2021 | SOU EXTENSION 4 GRANTED |
| Monday, April 12, 2021 | SOU EXTENSION 4 FILED |
| Monday, April 12, 2021 | TEAS EXTENSION RECEIVED |
| Monday, April 12, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, April 12, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 12, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 12, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 12, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, October 15, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 14, 2020 | SOU EXTENSION 3 GRANTED |
| Monday, October 12, 2020 | SOU EXTENSION 3 FILED |
| Monday, October 12, 2020 | TEAS EXTENSION RECEIVED |
| Monday, October 12, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, October 12, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 12, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 12, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 12, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 7, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 6, 2020 | SOU EXTENSION 2 GRANTED |
| Wednesday, April 1, 2020 | SOU EXTENSION 2 FILED |
| Friday, April 3, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, April 1, 2020 | TEAS EXTENSION RECEIVED |
| Wednesday, April 1, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, April 1, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, April 1, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, April 1, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, April 1, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, October 15, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 11, 2019 | SOU EXTENSION 1 GRANTED |
| Friday, October 11, 2019 | SOU EXTENSION 1 FILED |
| Friday, October 11, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, July 3, 2019 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, April 16, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 19, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 19, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 30, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 11, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, January 11, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 11, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Friday, January 11, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, January 11, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Friday, January 11, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, December 7, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 7, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 7, 2018 | ASSIGNED TO LIE |
| Monday, December 3, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 28, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 28, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, June 28, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 26, 2018 | ASSIGNED TO EXAMINER |
| Thursday, March 22, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 19, 2018 | NEW APPLICATION ENTERED |